Hibiclens
NDC 76420-535, Chlorhexidine Gluconate, solution, from Asclemed USA, Inc..
- Product NDC
- 76420-535
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA017768
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHLORHEXIDINE GLUCONATE4 g/100mL
Pharmacologic classes
Decreased Cell Wall Integrity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-535-08 | 76420053508 | 236 mL in 1 BOTTLE (76420-535-08) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 76420-535 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.